Vote Scores
Filings read through

Fate Therapeutics, Inc.: how funds voted at the meeting of 29 May 2025

Ticker
FATE
Meeting
Season
year to 30 June 2025
Filers reporting
209
Ballot items
7

209 filers on Form N-PX reported votes at the Fate Therapeutics, Inc. meeting of 29 May 2025. The records fall into 7 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of Fate Therapeutics, Inc. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2025. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    3 nominees. 96.0% of the reported votes are for. 10 filers withheld from or voted against at least one nominee.

    399 vote records from 72 filers. 1 of the 72 filers that marked the item voted against management.

    • Positions of 32 fund families
    • For 32
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    307 vote records from 207 filers. 57 of the 197 filers that marked the item voted against management. 10 filers gave no management mark.

    • Positions of 39 fund families
    • For 26
    • Against 13
    • Against management 13
  3. Item 3: Frequency of the say-on-pay vote

    One year: 179 filers. Three years: 6 filers. For: 4 filers. Abstain: 2 filers. Not voted: 1 filer. 1-year: 1 filer.

    300 vote records from 205 filers. 10 of the 195 filers that marked the item voted against management. 10 filers gave no management mark.

    • Positions of 39 fund families
    • Split or no vote 39
    • Against management 2
  4. Item 4: Audit-related items (auditor ratification)

    133 vote records from 72 filers. 2 of the 72 filers that marked the item voted against management.

    • Positions of 32 fund families
    • For 32
  5. Item 5: CAPITAL STRUCTURE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    133 vote records from 72 filers. 2 of the 72 filers that marked the item voted against management.

    • Positions of 32 fund families
    • For 31
    • Against 1
    • Against management 1
  6. Item 6: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    135 vote records from 74 filers. 43 of the 74 filers that marked the item voted against management.

    • Positions of 32 fund families
    • For 11
    • Against 21
    • Against management 20
  7. Item 7: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    133 vote records from 72 filers. 39 of the 72 filers that marked the item voted against management.

    • Positions of 32 fund families
    • For 14
    • Against 18
    • Against management 18

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Fate Therapeutics, Inc., meeting of 29 May 2025Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Pay-vote frequency4. Auditor
AllianceBernsteinAgainst, against managementSplitNo report
BlackRock and iSharesForSplitFor
BNY MellonForSplitNo report
Charles SchwabForSplitFor
Columbia ThreadneedleForSplitFor
DimensionalAgainst, against managementSplit, against managementFor
DWSForSplitFor
EquitableAgainst, against managementSplitFor
Federated HermesAgainst, against managementSplitFor
FidelityForSplitFor
First TrustForSplitNo report
Franklin TempletonForSplitNo report
Global XAgainst, against managementSplitFor
Goldman SachsForSplitFor
Guggenheim and RydexForSplitFor
InvescoAgainst, against managementSplitFor
J.P. MorganForSplitFor
Jackson National fundsAgainst, against managementSplit, against managementFor
John Hancock and ManulifeForSplitFor
Lincoln FinancialForSplitFor
Morgan Stanley, Eaton Vance and CalvertAgainst, against managementSplitFor
NationwideForSplitFor
Natixis and Loomis SaylesAgainst, against managementSplitNo report
Neuberger BermanAgainst, against managementSplitNo report
Northern Trust and FlexSharesForSplitFor
Nuveen and TIAAForSplitFor
Pacific Life fundsForSplitFor
PGIM and PrudentialAgainst, against managementSplitFor
PrincipalForSplitNo report
ProShares and ProFundsForSplitFor
Russell InvestmentsAgainst, against managementSplitFor
SEIAgainst, against managementSplitFor
State Street and SPDRForSplitFor
T. Rowe PriceForSplitFor
ThriventForSplitFor
VanguardForSplitFor
Victory CapitalForSplitFor
VoyaForSplitFor
WisdomTreeForSplitFor

Questions

How many filers reported votes at the Fate Therapeutics, Inc. meeting?
209 Form N-PX filers reported votes at the meeting of 29 May 2025. On say-on-pay, 57 of 197 filers that marked the item voted against management (28.9%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Fate Therapeutics, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Fate Therapeutics, Inc. with a meeting date within three days of 29 May 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .